Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.
To provide evidence-based recommendations for patients with metastatic castration-resistant prostate cancer (mCRPC). An Expert Panel including patient representation completed a systematic review of the evidence and made recommendations. Depending upon …